Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

47.96 -1.89 (-3.79%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
33 34 Next >
MarketBeat Week in Review – 02/17 - 02/21
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news 
Via MarketBeat
Topics Economy
Don't Call It A Stock Market Crash
A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way. 
Via Talk Markets
Topics ETFs Stocks / Equities
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug Administration (FDA) reported that the shortage of weight-loss drugs such as... 
Via StockStory
Topics Artificial Intelligence
Why Hims & Hers Health Stock Is Plummeting Today
Via The Motley Fool
Why Novo Nordisk Stock Popped on Friday
Via The Motley Fool
Top movers in Friday's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Stocks Firmly Lower As Consumer Sentiment Weakens
The Dow Jones Industrial Average is headed for another sharp triple-digit drop to end the week. 
Via Talk Markets
Topics Stocks Stocks / Equities
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized treatments. Also, in another development, FDA resolves semaglutide injection... 
Via Benzinga
Topics Economy
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
The FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved. 
Via Investor's Business Daily
Hims & Hers Acquires US-based Peptide Facility
From Hims & Hers
Via Business Wire
Why the growth investor may take a look at NYSE:HIMS.
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations 
Via Chartmill
Why Hims & Hers Stock Dropped Today
Via The Motley Fool
Market Whales and Their Recent Bets on HIMS Options
Via Benzinga
Buy HIMS Stock Here
In this video, I provide my technical analysis for how I would manage the risk and book the profits on the trade. 
Via Talk Markets
Topics Stocks / Equities
Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided
One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance. 
Via Stocktwits
Why Hims & Hers Health Stock Is Skyrocketing Today
Via The Motley Fool
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 24.8% in the afternoon session after the company announced the acquisition of Sigmund (marketed as Trybe Labs), which will allow it to... 
Via StockStory
Topics Artificial Intelligence
What Is Driving Hims & Hers Stock Higher?
The stock is up 140% this year already. 
Via The Motley Fool
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Via Benzinga
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime. 
Via The Motley Fool
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Hims & Hers Health Stock Hits All-Time Highs: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab testing. Positive analyst coverage may also be boosting the stock. Here's what... 
Via Benzinga
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
From Hims & Hers
Via Business Wire
Hims & Hers Earnings Could Be a Game Changer—What to Do Now
After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements. 
Via MarketBeat
3 Hot Stocks That Have Already Doubled in 2025
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year. 
Via The Motley Fool
Hims & Hers Stock Is On Fire, But Is It a Bubble?
The stock isn't as expensive as you might think. 
Via The Motley Fool
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Hims & Hers: From Viral Ad to Volatile Stock
Hims & Hers leverages its viral Super Bowl advertisement and strategic weight loss market entry to achieve stock gains and brand recognition in telehealth. 
Via MarketBeat
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.